Patrick Ho

2.1k total citations
25 papers, 750 citations indexed

About

Patrick Ho is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Patrick Ho has authored 25 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Neurology and 8 papers in Oncology. Recurrent topics in Patrick Ho's work include Parkinson's Disease Mechanisms and Treatments (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (5 papers). Patrick Ho is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (5 papers). Patrick Ho collaborates with scholars based in Singapore, United States and Switzerland. Patrick Ho's co-authors include Yi Zhao, Zhidong Zhou, Qizhi Tang, Eng‐King Tan, Shao Xie, Dario C. Angeles, Eng King Tan, Lei Zhou, Émilie Ronin and Yvonne Y. Chen and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and Human Molecular Genetics.

In The Last Decade

Patrick Ho

23 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Ho Singapore 16 323 249 176 152 127 25 750
Song Shi China 18 138 0.4× 634 2.5× 174 1.0× 207 1.4× 93 0.7× 28 1.0k
Wenyuan Guo China 16 249 0.8× 273 1.1× 41 0.2× 109 0.7× 58 0.5× 52 848
Mathieu Marella United States 18 135 0.4× 794 3.2× 91 0.5× 122 0.8× 50 0.4× 35 1.1k
Dianbo Qu Canada 18 248 0.8× 720 2.9× 140 0.8× 155 1.0× 54 0.4× 33 1.1k
Weijin Liu China 11 206 0.6× 339 1.4× 62 0.4× 116 0.8× 39 0.3× 21 684
Samira Ghorbani Canada 18 95 0.3× 471 1.9× 53 0.3× 67 0.4× 206 1.6× 34 992
Zengli Zhang China 11 53 0.2× 226 0.9× 63 0.4× 80 0.5× 65 0.5× 18 544
Piotr Zabrocki Belgium 11 257 0.8× 444 1.8× 45 0.3× 155 1.0× 30 0.2× 17 715
Paul Felten Luxembourg 9 116 0.4× 367 1.5× 54 0.3× 149 1.0× 90 0.7× 10 711

Countries citing papers authored by Patrick Ho

Since Specialization
Citations

This map shows the geographic impact of Patrick Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Ho more than expected).

Fields of papers citing papers by Patrick Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Ho. The network helps show where Patrick Ho may publish in the future.

Co-authorship network of co-authors of Patrick Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Ho. A scholar is included among the top collaborators of Patrick Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Ho. Patrick Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Patrick, Céline Grégoire, AnneMarie W. Block, et al.. (2025). Fine tuning towards the next generation of engineered T cells. Nature Biomedical Engineering. 9(10). 1610–1631.
2.
Ho, Patrick, Ellen Cahir-McFarland, Jason D. Fontenot, et al.. (2024). Harnessing regulatory T cells to establish immune tolerance. Science Translational Medicine. 16(738). eadm8859–eadm8859. 24 indexed citations
3.
Raskó, Tamás, et al.. (2024). Current Non-Viral-Based Strategies to Manufacture CAR-T Cells. International Journal of Molecular Sciences. 25(24). 13685–13685. 3 indexed citations
4.
Müller, Yannick D., Patrick Ho, Jeffrey A. Bluestone, & Qizhi Tang. (2024). Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine. 15(8). a041599–a041599.
5.
Tan, Boon Chin, et al.. (2024). Genome-Wide Analysis of the R2R3-MYB Gene Family in Durian (Durio zibethinus) and Potential Role in Nutrient Stress Response. Tropical Plant Biology. 18(1). 1 indexed citations
6.
Zhou, Zhidong, Patrick Ho, Li Zeng, et al.. (2022). The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis. Cellular and Molecular Life Sciences. 79(12). 599–599. 35 indexed citations
7.
Wagner, Johanna, Émilie Ronin, Patrick Ho, Yani Peng, & Qizhi Tang. (2022). Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival. American Journal of Transplantation. 22(9). 2237–2245. 44 indexed citations
8.
Müller, Yannick D., Duy Nguyen, Leonardo M. R. Ferreira, et al.. (2021). The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28. Frontiers in Immunology. 12. 639818–639818. 85 indexed citations
9.
Müller, Yannick D., Leonardo M. R. Ferreira, Émilie Ronin, et al.. (2021). Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance. Frontiers in Immunology. 12. 686439–686439. 63 indexed citations
10.
Ho, Patrick, et al.. (2021). Identification of Targets from LRRK2 Rescue Phenotypes. Cells. 10(1). 76–76. 4 indexed citations
11.
Ho, Patrick, et al.. (2017). Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity. ACS Synthetic Biology. 6(8). 1484–1495. 18 indexed citations
12.
Ho, Patrick & Yvonne Y. Chen. (2017). Mammalian synthetic biology in the age of genome editing and personalized medicine. Current Opinion in Chemical Biology. 40. 57–64. 14 indexed citations
13.
Angeles, Dario C., Patrick Ho, Cheng Wang, et al.. (2014). Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. Human Molecular Genetics. 23(12). 3157–3165. 42 indexed citations
14.
Wang, Huashan, et al.. (2014). In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila. Molecular Brain. 7(1). 73–73. 32 indexed citations
15.
Zhou, Zhidong, Shao Xie, Patrick Ho, et al.. (2013). Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons. Free Radical Biology and Medicine. 68. 220–233. 24 indexed citations
16.
Zhao, Yi, Patrick Ho, Kumar‐M. Prakash, et al.. (2012). Analysis of EIF4G1 in Parkinson's disease among Asians. Neurobiology of Aging. 34(4). 1311.e5–1311.e6. 16 indexed citations
17.
Tan, Eng-King, Rong Peng, Yik-Ying Teo, et al.. (2010). MultipleLRRK2variants modulate risk of Parkinson disease: a Chinese multicenter study. Human Mutation. 31(5). n/a–n/a. 88 indexed citations
18.
Zhao, Yi, et al.. (2009). LRRK2 variant associated with Alzheimer's disease. Neurobiology of Aging. 32(11). 1990–1993. 28 indexed citations
19.
Tan, Eng‐King, et al.. (2009). CALHM1 variant is not associated with Alzheimer's disease among Asians. Neurobiology of Aging. 32(3). 546.e11–546.e12. 13 indexed citations
20.
Tan, Eng‐King, et al.. (2009). Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect. Human Mutation. 30(11). 1551–1557. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026